Sunday, July 16, 2017 9:33:25 PM
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.859 Volume: 193,980
$ Intraday High: 0.867 % Change: 3.482
$ Change: 0.029 $ Volume: 166,609
$ Open: 0.867
$ Previous Close: 0.830
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 291,534
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 7/14/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.859 Volume: 193,980
$ Intraday High: 0.867 % Change: 3.482
$ Change: 0.029 $ Volume: 166,609
$ Open: 0.867
$ Previous Close: 0.830
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 291,534
Promoter: OTC Tip Reporter
Compensation: To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated THIRD party for marketing exposure on ITUS beginning on July 12th, 2017 ending on July 14th, 2017.
Date: 7/14/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.830 Volume: 968,974
$ Intraday High: 0.950 % Change: 7.806
$ Change: 0.060 $ Volume: 804,248
$ Open: 0.872
$ Previous Close: 0.770
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 288,693
Promoter: OTC Tip Reporter
Compensation: To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure on ITUS beginning on July 12th, 2017 ending on July 14th, 2017.
Date: 7/13/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.830 Volume: 968,974
$ Intraday High: 0.950 % Change: 7.806
$ Change: 0.060 $ Volume: 804,248
$ Open: 0.872
$ Previous Close: 0.770
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 288,693
Promoter: The Penny Stock Hero
Compensation: Hero Team We have been compensated 2K by Cream Consulting LLC for distribution of this email on ITUS TSPS, Somwar Peth, Pune, MH 85207, INDIA Unsubscribe | Change Subscriber Options
Date: 7/13/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.830 Volume: 968,974
$ Intraday High: 0.950 % Change: 7.806
$ Change: 0.060 $ Volume: 804,248
$ Open: 0.872
$ Previous Close: 0.770
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 288,693
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 7/13/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.170 Volume: 685,670
$ Intraday High: 1.320 % Change: 1.739
$ Change: 0.020 $ Volume: 802,234
$ Open: 1.270
$ Previous Close: 1.150
3 Month: $ High / Low 3.050 / 0.710 Volume 3m avg: 249,490
Promoter: The Penny Stock Hero
Compensation: Hero Team Please make sure to read and understand our complete disclaimer below (image file) We have been compensated 2K by Cream Consulting LLC for distribution of this email on ITUS TSPS, Somwar Peth, Pune, MH 85207, INDIA Unsubscribe | Change Subscriber Options
Date: 7/3/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.170 Volume: 685,670
$ Intraday High: 1.320 % Change: 1.739
$ Change: 0.020 $ Volume: 802,234
$ Open: 1.270
$ Previous Close: 1.150
3 Month: $ High / Low 3.050 / 0.710 Volume 3m avg: 249,490
Promoter: OTC Tip Reporter
Compensation: To date we have been compensated Sixty Five Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty Five Thousand dollars USD by a non-affiliated third party FOR marketing exposure.
Date: 7/3/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.170 Volume: 685,670
$ Intraday High: 1.320 % Change: 1.739
$ Change: 0.020 $ Volume: 802,234
$ Open: 1.270
$ Previous Close: 1.150
3 Month: $ High / Low 3.050 / 0.710 Volume 3m avg: 249,490
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 7/3/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.150 Volume: 1,630,514
$ Intraday High: 1.200 % Change: 19.779
$ Change: 0.190 $ Volume: 1,875,091
$ Open: 0.990
$ Previous Close: 0.960
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 194,375
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 6/28/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.150 Volume: 1,630,514
$ Intraday High: 1.200 % Change: 19.779
$ Change: 0.190 $ Volume: 1,875,091
$ Open: 0.990
$ Previous Close: 0.960
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 194,375
Promoter: OTC Tip Reporter
Compensation: Please be advised we have been compensated for investor relations and media services for ITUS in THE amount of Thirty Thousand dollars USD by, a non-affiliated third party for marketing exposure which has since expired.
Date: 6/28/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.040 Volume: 1,632,779
$ Intraday High: 1.140 % Change: 40.541
$ Change: 0.300 $ Volume: 1,698,090
$ Open: 0.900
$ Previous Close: 0.740
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 165,079
Promoter: OTC Tip Reporter
Compensation: Please be advised we have been compensated for inve.stor relations and media services for ITUS in THE amount of Thirty Thousand dollars USD by, a non-affiliated third party for marketing exposure.
Date: 6/26/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.040 Volume: 1,632,779
$ Intraday High: 1.140 % Change: 40.541
$ Change: 0.300 $ Volume: 1,698,090
$ Open: 0.900
$ Previous Close: 0.740
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 165,079
Promoter: The Penny Stock Hero
Compensation: Trade Green, The Hero Team Please make sure to read and understand our disclaimer below (image file) We have been compensated 2K by Cream Consulting LLC for distribution of this email on ITUS TSPS, Somwar Peth, Pune, MH 85207, INDIA Unsubscribe | Change Subscriber Options
Date: 6/26/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.040 Volume: 1,632,779
$ Intraday High: 1.140 % Change: 40.541
$ Change: 0.300 $ Volume: 1,698,090
$ Open: 0.900
$ Previous Close: 0.740
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 165,079
Promoter: Penny Stock Prophet
Compensation: Please be advised we have been compensated for inv.estor relations and media services for ITUS in THE amount of Thirty Thousand dollars USD by, a non-affiliated third party for marketing exposure.
Date: 6/26/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Recent ANIX News
- Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board • PR Newswire (US) • 04/18/2024 12:20:00 PM
- Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties • PR Newswire (US) • 03/14/2024 12:45:00 PM
- Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress • PR Newswire (US) • 03/11/2024 12:00:00 PM
- Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial • PR Newswire (US) • 02/12/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/08/2024 09:15:32 PM
- Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference • PR Newswire (US) • 01/29/2024 01:50:00 PM
- Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology • PR Newswire (US) • 01/23/2024 12:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:08:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:07:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:07:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:05:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:05:16 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/16/2024 10:29:43 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/16/2024 09:43:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/16/2024 09:30:49 PM
- Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024 • PR Newswire (US) • 01/10/2024 02:00:00 PM
- Anixa Biosciences to Present at Biotech Showcase 2024 • PR Newswire (US) • 12/14/2023 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 11:01:47 AM
- Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine • PR Newswire (US) • 12/06/2023 11:00:00 PM
- Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine • PR Newswire (US) • 12/06/2023 09:05:00 PM
- Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology • PR Newswire (US) • 11/27/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 02:58:20 PM
- Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference • PR Newswire (US) • 10/31/2023 12:30:00 PM
- Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board • PR Newswire (US) • 10/23/2023 12:30:00 PM
- Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial • PR Newswire (US) • 10/13/2023 12:30:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM